A 0 1 0 1 O
combination 2 13 2 13 O
of 14 16 14 16 O
small 17 22 17 22 B-cancer
cell 23 27 23 27 I-cancer
and 28 31 28 31 O
non 32 35 32 35 B-cancer
- 35 36 35 36 I-cancer
small 36 41 36 41 I-cancer
cell 42 46 42 46 I-cancer
lung 47 51 47 51 I-cancer
cancer 52 58 52 58 I-cancer
, 58 59 58 59 O
pulmonary 60 69 60 69 B-cancer
carcinoid 70 79 70 79 I-cancer
tumour 80 86 80 86 I-cancer
or 87 89 87 89 O
large 90 95 90 95 B-cancer
- 95 96 95 96 I-cancer
cell 96 100 96 100 I-cancer
neuroendocrine 101 115 101 115 I-cancer
carcinoma 116 125 116 125 I-cancer
( 126 127 126 127 I-cancer
LCNEC 127 132 127 132 I-cancer
) 132 133 132 133 I-cancer

All 0 3 134 137 O
gross 4 9 138 143 O
disease 10 17 144 151 O
must 18 22 152 156 O
have 23 27 157 161 O
been 28 32 162 166 O
removed 33 40 167 174 O
at 41 43 175 177 O
the 44 47 178 181 O
end 48 51 182 185 O
of 52 54 186 188 O
surgery 55 62 189 196 B-treatment

All 0 3 197 200 O
surgical 4 12 201 209 O
margins 13 20 210 217 O
of 21 23 218 220 O
resection 24 33 221 230 O
must 34 38 231 235 O
be 39 41 236 238 O
negative 42 50 239 247 O
for 51 54 248 251 O
tumour 55 61 252 258 B-cancer

Complete 0 8 259 267 B-treatment
surgical 9 17 268 276 I-treatment
resection 18 27 277 286 I-treatment
of 28 30 287 289 O
the 31 34 290 293 O
primary 35 42 294 301 O
NSCLC 43 48 302 307 B-cancer
is 49 51 308 310 O
also 52 56 311 315 O
mandatory 57 66 316 325 O

Concurrent 0 10 326 336 O
treatment 11 20 337 346 B-treatment
with 21 25 347 351 O
other 26 31 352 357 O
investigational 32 47 358 373 B-treatment
drugs 48 53 374 379 I-treatment
or 54 56 380 382 O
anti 57 61 383 387 B-treatment
- 61 62 387 388 I-treatment
cancer 62 68 388 394 I-treatment
therapy 69 76 395 402 I-treatment

Creatinine 0 10 403 413 O
clearance 11 20 414 423 O
to 21 23 424 426 O
be 24 26 427 429 O
measured 27 35 430 438 O
directly 36 44 439 447 O
by 45 47 448 450 O
24 48 50 451 453 B-upper_bound
hour 51 55 454 458 I-upper_bound
urine 56 61 459 464 O
sampling 62 70 465 473 O
or 71 73 474 476 O
as 74 76 477 479 O
calculated 77 87 480 490 O
by 88 90 491 493 O
Cockcroft 91 100 494 503 O
Formula 101 108 504 511 O

Females 0 7 512 519 B-gender
: 7 8 519 520 O
GFR 9 12 521 524 B-clinical_variable
= 13 14 525 526 O
1.04 15 19 527 531 O
x 20 21 532 533 O
( 22 23 534 535 O
140 23 26 535 538 O
- 26 27 538 539 O
age 27 30 539 542 B-age
) 30 31 542 543 O
x 32 33 544 545 O
weight 34 40 546 552 B-clinical_variable
in 41 43 553 555 O
kg 44 46 556 558 O
serum 47 52 559 564 O
creatinine 53 63 565 575 O
in 64 66 576 578 O
μmol 67 71 579 583 O
/ 71 72 583 584 O
L 72 73 584 585 O

Hematology 0 10 586 596 O
: 10 11 596 597 O
. 12 13 598 599 O
Absolute 14 22 600 608 B-clinical_variable
neutrophil 23 33 609 619 I-clinical_variable
count 34 39 620 625 I-clinical_variable
≥ 40 41 626 627 O
1.5 42 45 628 631 B-lower_bound
x 46 47 632 633 I-lower_bound
109 48 51 634 637 I-lower_bound
/ 51 52 637 638 I-lower_bound
L 52 53 638 639 I-lower_bound
or 54 56 640 642 O
≥ 57 58 643 644 O
1,500/µl 59 67 645 653 B-lower_bound
Platelets 68 77 654 663 B-clinical_variable
≥ 78 79 664 665 O
100 80 83 666 669 B-lower_bound
x 84 85 670 671 I-lower_bound
109 86 89 672 675 I-lower_bound
/ 89 90 675 676 I-lower_bound
L 90 91 676 677 I-lower_bound
or 92 94 678 680 O
≥ 95 96 681 682 O
100,000/µl 97 107 683 693 B-lower_bound

Histologically 0 14 694 708 O
confirmed 15 24 709 718 O
diagnosis 25 34 719 728 O
of 35 37 729 731 O
primary 38 45 732 739 O
non 46 49 740 743 B-cancer
- 49 50 743 744 I-cancer
small 50 55 744 749 I-cancer
cell 56 60 750 754 I-cancer
carcinoma 61 70 755 764 I-cancer
of 71 73 765 767 O
the 74 77 768 771 O
lung 78 82 772 776 O

History 0 7 777 784 O
of 8 10 785 787 O
autoimmune 11 21 788 798 B-chronic_disease
disease 22 29 799 806 I-chronic_disease
, 29 30 806 807 O
including 31 40 808 817 O
but 41 44 818 821 O
not 45 48 822 825 O
limited 49 56 826 833 O
to 57 59 834 836 O
myasthenia 60 70 837 847 B-chronic_disease
gravis 71 77 848 854 I-chronic_disease
, 77 78 854 855 O
myositis 79 87 856 864 B-chronic_disease
, 87 88 864 865 O
autoimmune 89 99 866 876 B-chronic_disease
hepatitis 100 109 877 886 I-chronic_disease
, 109 110 886 887 O
systemic 111 119 888 896 B-chronic_disease
lupus 120 125 897 902 I-chronic_disease
erythematosus 126 139 903 916 I-chronic_disease
, 139 140 916 917 O
rheumatoid 141 151 918 928 B-chronic_disease
arthritis 152 161 929 938 I-chronic_disease
, 161 162 938 939 O
inflammatory 163 175 940 952 B-chronic_disease
bowel 176 181 953 958 I-chronic_disease
disease 182 189 959 966 I-chronic_disease
, 189 190 966 967 O
vascular 191 199 968 976 B-chronic_disease
thrombosis 200 210 977 987 I-chronic_disease
associated 211 221 988 998 O
with 222 226 999 1003 O
antiphospholipid 227 243 1004 1020 B-chronic_disease
syndrome 244 252 1021 1029 I-chronic_disease
, 252 253 1029 1030 O
Wegener 254 261 1031 1038 B-chronic_disease
's 261 263 1038 1040 I-chronic_disease
granulomatosis 264 278 1041 1055 I-chronic_disease
, 278 279 1055 1056 O
Sjögren 280 287 1057 1064 B-chronic_disease
's 287 289 1064 1066 I-chronic_disease
syndrome 290 298 1067 1075 I-chronic_disease
, 298 299 1075 1076 O
Guillain 300 308 1077 1085 B-chronic_disease
- 308 309 1085 1086 I-chronic_disease
Barré 309 314 1086 1091 I-chronic_disease
syndrome 315 323 1092 1100 I-chronic_disease
, 323 324 1100 1101 O
multiple 325 333 1102 1110 B-chronic_disease
sclerosis 334 343 1111 1120 I-chronic_disease
, 343 344 1120 1121 O
vasculitis 345 355 1122 1132 B-chronic_disease
, 355 356 1132 1133 O
or 357 359 1134 1136 O
glomerulonephritis 360 378 1137 1155 B-chronic_disease
. 378 379 1155 1156 O
NOTE 380 384 1157 1161 O
: 384 385 1161 1162 O
patients 386 394 1163 1171 O
with 395 399 1172 1176 O
Grave 400 405 1177 1182 B-chronic_disease
's 405 407 1182 1184 I-chronic_disease
disease 408 415 1185 1192 I-chronic_disease
and/or 416 422 1193 1199 O
psoriasis 423 432 1200 1209 B-chronic_disease
not 433 436 1210 1213 O
requiring 437 446 1214 1223 O
systemic 447 455 1224 1232 B-treatment
therapy 456 463 1233 1240 I-treatment
within 464 470 1241 1247 O
the 471 474 1248 1251 O
last 475 479 1252 1256 B-upper_bound
two 480 483 1257 1260 I-upper_bound
years 484 489 1261 1266 I-upper_bound
from 490 494 1267 1271 O
randomization 495 508 1272 1285 O
and 509 512 1286 1289 O
patients 513 521 1290 1298 O
with 522 526 1299 1303 O
hypothyroidism 527 541 1304 1318 B-chronic_disease
( 542 543 1319 1320 O
e.g. 543 547 1320 1324 O
following 548 557 1325 1334 O
Hashimoto 558 567 1335 1344 B-chronic_disease
syndrome 568 576 1345 1353 I-chronic_disease
) 576 577 1353 1354 O
stable 578 584 1355 1361 O
on 585 587 1362 1364 O
hormone 588 595 1365 1372 B-treatment
replacement 596 607 1373 1384 I-treatment
are 608 611 1385 1388 O
not 612 615 1389 1392 O
excluded 616 624 1393 1401 O

History 0 7 1402 1409 O
of 8 10 1410 1412 O
hypersensitivity 11 27 1413 1429 O
to 28 30 1430 1432 O
MEDI4736 31 39 1433 1441 B-allergy_name
or 40 42 1442 1444 O
any 43 46 1445 1448 O
excipient 47 56 1449 1458 B-allergy_name

History 0 7 1459 1466 O
of 8 10 1467 1469 O
primary 11 18 1470 1477 B-chronic_disease
immunodeficiency 19 35 1478 1494 I-chronic_disease
, 35 36 1494 1495 O
history 37 44 1496 1503 O
of 45 47 1504 1506 O
allogenic 48 57 1507 1516 B-treatment
organ 58 63 1517 1522 I-treatment
transplant 64 74 1523 1533 I-treatment
that 75 79 1534 1538 O
requires 80 88 1539 1547 O
therapeutic 89 100 1548 1559 B-treatment
immunosuppression 101 118 1560 1577 I-treatment
and 119 122 1578 1581 O
the 123 126 1582 1585 O
use 127 130 1586 1589 O
of 131 133 1590 1592 O
immunosuppressive 134 151 1593 1610 B-treatment
agents 152 158 1611 1617 I-treatment
within 159 165 1618 1624 O
28 166 168 1625 1627 B-upper_bound
days 169 173 1628 1632 I-upper_bound
of 174 176 1633 1635 O
randomization 177 190 1636 1649 O
* 190 191 1649 1650 O
or 192 194 1651 1653 O
a 195 196 1654 1655 O
prior 197 202 1656 1661 O
history 203 210 1662 1669 O
of 211 213 1670 1672 O
severe 214 220 1673 1679 O
( 221 222 1680 1681 O
grade 222 227 1681 1686 B-lower_bound
3 228 229 1687 1688 I-lower_bound
or 230 232 1689 1691 O
4 233 234 1692 1693 B-upper_bound
) 234 235 1693 1694 O
immune 236 242 1695 1701 O
mediated 243 251 1702 1710 O
toxicity 252 260 1711 1719 O
from 261 265 1720 1724 O
other 266 271 1725 1730 O
immune 272 278 1731 1737 B-treatment
therapy 279 286 1738 1745 I-treatment

Inability 0 9 1746 1755 O
( 10 11 1756 1757 O
illiteracy 11 21 1757 1767 O
, 21 22 1767 1768 O
loss 23 27 1769 1773 B-chronic_disease
of 28 30 1774 1776 I-chronic_disease
sight 31 36 1777 1782 I-chronic_disease
, 36 37 1782 1783 O
or 38 40 1784 1786 O
other 41 46 1787 1792 O
equivalent 47 57 1793 1803 O
reason 58 64 1804 1810 O
) 64 65 1810 1811 O
to 66 68 1812 1814 O
complete 69 77 1815 1823 O
the 78 81 1824 1827 O
questionnaires 82 96 1828 1842 O
will 97 101 1843 1847 O
not 102 105 1848 1851 O
make 106 110 1852 1856 O
the 111 114 1857 1860 O
patient 115 122 1861 1868 O
ineligible 123 133 1869 1879 O
for 134 137 1880 1883 O
the 138 141 1884 1887 O
study 142 147 1888 1893 O

Investigators 0 13 1894 1907 O
must 14 18 1908 1912 O
assure 19 25 1913 1919 O
themselves 26 36 1920 1930 O
the 37 40 1931 1934 O
patients 41 49 1935 1943 O
randomized 50 60 1944 1954 O
on 61 63 1955 1957 O
this 64 68 1958 1962 O
trial 69 74 1963 1968 O
will 75 79 1969 1973 O
be 80 82 1974 1976 O
available 83 92 1977 1986 O
for 93 96 1987 1990 O
complete 97 105 1991 1999 O
documentation 106 119 2000 2013 O
of 120 122 2014 2016 O
the 123 126 2017 2020 O
treatment 127 136 2021 2030 B-treatment
, 136 137 2030 2031 O
adverse 138 145 2032 2039 O
events 146 152 2040 2046 O
, 152 153 2046 2047 O
and 154 157 2048 2051 O
follow 158 164 2052 2058 O
- 164 165 2058 2059 O
up 165 167 2059 2061 O

Live 0 4 2062 2066 B-treatment
attenuated 5 15 2067 2077 I-treatment
vaccination 16 27 2078 2089 I-treatment
administered 28 40 2090 2102 O
within 41 47 2103 2109 O
30 48 50 2110 2112 B-upper_bound
days 51 55 2113 2117 I-upper_bound
prior 56 61 2118 2123 I-upper_bound
to 62 64 2124 2126 O
randomization 65 78 2127 2140 O

Males 0 5 2141 2146 B-gender
: 5 6 2146 2147 O
GFR 7 10 2148 2151 B-clinical_variable
= 11 12 2152 2153 O
1.23 13 17 2154 2158 O
x 18 19 2159 2160 O
( 20 21 2161 2162 O
140 21 24 2162 2165 O
- 24 25 2165 2166 O
age 25 28 2166 2169 B-age
) 28 29 2169 2170 O
x 30 31 2171 2172 O
weight 32 38 2173 2179 O
in 39 41 2180 2182 O
kg 42 44 2183 2185 O
serum 45 50 2186 2191 B-clinical_variable
creatinine 51 61 2192 2202 I-clinical_variable
in 62 64 2203 2205 O
μmol 65 69 2206 2210 O
/ 69 70 2210 2211 O
L 70 71 2211 2212 O

Men 0 3 2213 2216 B-gender

No 0 2 2217 2219 O
prior 3 8 2220 2225 O
anticancer 9 19 2226 2236 B-treatment
therapy 20 27 2237 2244 I-treatment
for 28 31 2245 2248 O
treatment 32 41 2249 2258 B-treatment
of 42 44 2259 2261 O
NSCLC 45 50 2262 2267 B-cancer
other 51 56 2268 2273 O
than 57 61 2274 2278 O
standard 62 70 2279 2287 O
post 71 75 2288 2292 O
- 75 76 2292 2293 O
operative 76 85 2293 2302 O
adjuvant 86 94 2303 2311 O
chemotherapy 95 107 2312 2324 B-treatment
is 108 110 2325 2327 O
permissible 111 122 2328 2339 O

Patients 0 8 2340 2348 O
may 9 12 2349 2352 O
have 13 17 2353 2357 O
received 18 26 2358 2366 O
prior 27 32 2367 2372 B-treatment
post 33 37 2373 2377 I-treatment
- 37 38 2377 2378 I-treatment
operative 38 47 2378 2387 I-treatment
platinum 48 56 2388 2396 I-treatment
based 57 62 2397 2402 O
chemotherapy 63 75 2403 2415 B-treatment
as 76 78 2416 2418 O
per 79 82 2419 2422 O
standard 83 91 2423 2431 O
of 92 94 2432 2434 O
care 95 99 2435 2439 O

Patients 0 8 2440 2448 O
must 9 13 2449 2453 O
be 14 16 2454 2456 O
accessible 17 27 2457 2467 O
for 28 31 2468 2471 O
treatment 32 41 2472 2481 B-treatment
and 42 45 2482 2485 O
follow 46 52 2486 2492 O
- 52 53 2492 2493 O
up 53 55 2493 2495 O

Patients 0 8 2496 2504 O
must 9 13 2505 2509 O
be 14 16 2510 2512 O
classified 17 27 2513 2523 O
post 28 32 2524 2528 O
- 32 33 2528 2529 O
operatively 33 44 2529 2540 O
as 45 47 2541 2543 O
Stage 48 53 2544 2549 B-lower_bound
IB 54 56 2550 2552 I-lower_bound
( 57 58 2553 2554 O
≥ 58 59 2554 2555 O
4 60 61 2556 2557 B-lower_bound
cm 61 63 2557 2559 I-lower_bound
in 64 66 2560 2562 O
the 67 70 2563 2566 O
longest 71 78 2567 2574 O
diameter 79 87 2575 2583 B-clinical_variable
) 87 88 2583 2584 O
, 88 89 2584 2585 O
II 90 92 2586 2588 O
or 93 95 2589 2591 O
IIIA 96 100 2592 2596 B-upper_bound
on 101 103 2597 2599 O
the 104 107 2600 2603 O
basis 108 113 2604 2609 O
of 114 116 2610 2612 O
pathologic 117 127 2613 2623 O
criteria 128 136 2624 2632 O

Patients 0 8 2633 2641 O
positive 9 17 2642 2650 O
for 18 21 2651 2654 O
hepatitis 22 31 2655 2664 B-chronic_disease
C 32 33 2665 2666 I-chronic_disease
( 34 35 2667 2668 I-chronic_disease
HCV 35 38 2668 2671 I-chronic_disease
) 38 39 2671 2672 I-chronic_disease
antibody 40 48 2673 2681 O
are 49 52 2682 2685 O
eligible 53 61 2686 2694 O
only 62 66 2695 2699 O
if 67 69 2700 2702 O
polymerase 70 80 2703 2713 B-treatment
chain 81 86 2714 2719 I-treatment
reaction 87 95 2720 2728 I-treatment
is 96 98 2729 2731 O
negative 99 107 2732 2740 O
for 108 111 2741 2744 O
HCV 112 115 2745 2748 B-chronic_disease
RA 116 118 2749 2751 I-chronic_disease

Patients 0 8 2752 2760 O
who 9 12 2761 2764 O
have 13 17 2765 2769 O
experienced 18 29 2770 2781 O
untreated 30 39 2782 2791 B-chronic_disease
and/or 40 46 2792 2798 O
uncontrolled 47 59 2799 2811 B-chronic_disease
cardiovascular 60 74 2812 2826 I-chronic_disease
conditions 75 85 2827 2837 I-chronic_disease
and/or 86 92 2838 2844 O
have 93 97 2845 2849 O
symptomatic 98 109 2850 2861 B-chronic_disease
cardiac 110 117 2862 2869 I-chronic_disease
dysfunction 118 129 2870 2881 I-chronic_disease
( 130 131 2882 2883 O
unstable 131 139 2883 2891 B-chronic_disease
angina 140 146 2892 2898 I-chronic_disease
, 146 147 2898 2899 O
congestive 148 158 2900 2910 B-chronic_disease
heart 159 164 2911 2916 I-chronic_disease
failure 165 172 2917 2924 I-chronic_disease
, 172 173 2924 2925 O
myocardial 174 184 2926 2936 B-chronic_disease
infarction 185 195 2937 2947 I-chronic_disease
within 196 202 2948 2954 O
the 203 206 2955 2958 O
previous 207 215 2959 2967 O
year 216 220 2968 2972 O
or 221 223 2973 2975 O
cardiac 224 231 2976 2983 B-chronic_disease
ventricular 232 243 2984 2995 I-chronic_disease
arrhythmias 244 255 2996 3007 I-chronic_disease
requiring 256 265 3008 3017 O
medication 266 276 3018 3028 B-treatment
, 276 277 3028 3029 O
history 278 285 3030 3037 O
of 286 288 3038 3040 O
2nd 289 292 3041 3044 B-lower_bound
or 293 295 3045 3047 O
3rd 296 299 3048 3051 B-upper_bound
degree 300 306 3052 3058 I-upper_bound
atrioventricular 307 323 3059 3075 B-chronic_disease
conduction 324 334 3076 3086 I-chronic_disease
defects 335 342 3087 3094 O
) 342 343 3094 3095 O

Patients 0 8 3096 3104 O
with 9 13 3105 3109 O
N2 14 16 3110 3112 B-cancer
disease 17 24 3113 3120 I-cancer
only 25 29 3121 3125 O
who 30 33 3126 3129 O
receive 34 41 3130 3137 O
adjuvant 42 50 3138 3146 O
post 51 55 3147 3151 B-treatment
- 55 56 3151 3152 I-treatment
operative 56 65 3152 3161 I-treatment
radiation 66 75 3162 3171 I-treatment
therapy 76 83 3172 3179 I-treatment
are 84 87 3180 3183 O
eligible 88 96 3184 3192 O
provided 97 105 3193 3201 O
they 106 110 3202 3206 O
meet 111 115 3207 3211 O
the 116 119 3212 3215 O
protocol 120 128 3216 3224 O
specified 129 138 3225 3234 O
timing 139 145 3235 3241 O
criteria 146 154 3242 3250 O
for 155 158 3251 3254 O
surgery 159 166 3255 3262 B-treatment
, 166 167 3262 3263 O
adjuvant 168 176 3264 3272 B-treatment
chemotherapy 177 189 3273 3285 I-treatment
and 190 193 3286 3289 O
randomization 194 207 3290 3303 O
. 207 208 3303 3304 O
Pre 209 212 3305 3308 B-treatment
- 212 213 3308 3309 I-treatment
operative 213 222 3309 3318 I-treatment
radiation 223 232 3319 3328 I-treatment
therapy 233 240 3329 3336 I-treatment
is 241 243 3337 3339 O
not 244 247 3340 3343 O
permissible 248 259 3344 3355 O

Patients 0 8 3356 3364 O
with 9 13 3365 3369 O
a 14 15 3370 3371 O
history 16 23 3372 3379 O
of 24 26 3380 3382 O
other 27 32 3383 3388 O
malignancies 33 45 3389 3401 B-cancer

Patients 0 8 3402 3410 O
with 9 13 3411 3415 O
a 14 15 3416 3417 O
past 16 20 3418 3422 O
or 21 23 3423 3425 O
resolved 24 32 3426 3434 O
hepatitis 33 42 3435 3444 B-chronic_disease
B 43 44 3445 3446 I-chronic_disease
infection 45 54 3447 3456 O
( 55 56 3457 3458 O
defined 56 63 3458 3465 O
as 64 66 3466 3468 O
presence 67 75 3469 3477 O
of 76 78 3478 3480 O
hepatitis 79 88 3481 3490 O
B 89 90 3491 3492 O
core 91 95 3493 3497 O
antibody 96 104 3498 3506 O
( 105 106 3507 3508 O
anti 106 110 3508 3512 O
- 110 111 3512 3513 O
HBc 111 114 3513 3516 O
) 114 115 3516 3517 O
and 116 119 3518 3521 O
absence 120 127 3522 3529 O
of 128 130 3530 3532 O
HBSAg 131 136 3533 3538 O
) 136 137 3538 3539 O
are 138 141 3540 3543 O
eligible 142 150 3544 3552 O

Patients 0 8 3553 3561 O
with 9 13 3562 3566 O
a 14 15 3567 3568 O
significant 16 27 3569 3580 O
cardiac 28 35 3581 3588 O
history 36 43 3589 3596 O
, 43 44 3596 3597 O
even 45 49 3598 3602 O
if 50 52 3603 3605 O
controlled 53 63 3606 3616 O
, 63 64 3616 3617 O
must 65 69 3618 3622 O
have 70 74 3623 3627 O
a 75 76 3628 3629 O
LVEF 77 81 3630 3634 B-clinical_variable
> 82 83 3635 3636 O
50 84 86 3637 3639 B-lower_bound
% 86 87 3639 3640 I-lower_bound
within 88 94 3641 3647 O
12 95 97 3648 3650 B-upper_bound
weeks 98 103 3651 3656 I-upper_bound
prior 104 109 3657 3662 I-upper_bound
to 110 112 3663 3665 O
randomization 113 126 3666 3679 O

Patients 0 8 3680 3688 O
with 9 13 3689 3693 O
active 14 20 3694 3700 B-chronic_disease
or 21 23 3701 3703 O
uncontrolled 24 36 3704 3716 B-chronic_disease
infections 37 47 3717 3727 I-chronic_disease
or 48 50 3728 3730 O
with 51 55 3731 3735 O
serious 56 63 3736 3743 O
illnesses 64 73 3744 3753 O
or 74 76 3754 3756 O
medical 77 84 3757 3764 O
conditions 85 95 3765 3775 O
which 96 101 3776 3781 O
would 102 107 3782 3787 O
not 108 111 3788 3791 O
permit 112 118 3792 3798 O
the 119 122 3799 3802 O
patient 123 130 3803 3810 O
to 131 133 3811 3813 O
be 134 136 3814 3816 O
managed 137 144 3817 3824 O
according 145 154 3825 3834 O
to 155 157 3835 3837 O
the 158 161 3838 3841 O
protocol 162 170 3842 3850 O

Patients 0 8 3851 3859 O
with 9 13 3860 3864 O
large 14 19 3865 3870 B-cancer
- 19 20 3870 3871 I-cancer
cell 20 24 3871 3875 I-cancer
neuroendocrine 25 39 3876 3890 I-cancer
carcinomas 40 50 3891 3901 I-cancer
are 51 54 3902 3905 O
not 55 58 3906 3909 O
eligible 59 67 3910 3918 O

Pre 0 3 3919 3922 B-treatment
- 3 4 3922 3923 I-treatment
operative 4 13 3923 3932 I-treatment
( 14 15 3933 3934 I-treatment
neo 15 18 3934 3937 I-treatment
- 18 19 3937 3938 I-treatment
adjuvant 19 27 3938 3946 I-treatment
) 27 28 3946 3947 I-treatment
platinum 29 37 3948 3956 I-treatment
based 38 43 3957 3962 I-treatment
or 44 46 3963 3965 I-treatment
other 47 52 3966 3971 I-treatment
chemotherapy 53 65 3972 3984 I-treatment
is 66 68 3985 3987 O
not 69 72 3988 3991 O
permissible 73 84 3992 4003 O

Pregnant 0 8 4004 4012 B-pregnancy
or 9 11 4013 4015 O
lactating 12 21 4016 4025 O
women 22 27 4026 4031 B-gender

Prior 0 5 4032 4037 B-treatment
Systemic 6 14 4038 4046 I-treatment
Therapy 15 22 4047 4054 I-treatment

Protocol 0 8 4055 4063 O
treatment 9 18 4064 4073 B-treatment
is 19 21 4074 4076 O
to 22 24 4077 4079 O
begin 25 30 4080 4085 O
within 31 37 4086 4092 O
2 38 39 4093 4094 B-upper_bound
working 40 47 4095 4102 O
days 48 52 4103 4107 O
of 53 55 4108 4110 O
patient 56 63 4111 4118 O
randomization 64 77 4119 4132 O

Radiation 0 9 4133 4142 B-treatment

Resection 0 9 4143 4152 B-treatment
may 10 13 4153 4156 O
be 14 16 4157 4159 O
accomplished 17 29 4160 4172 O
by 30 32 4173 4175 O
open 33 37 4176 4180 B-treatment
or 38 40 4181 4183 I-treatment
VATS 41 45 4184 4188 I-treatment
techniques 46 56 4189 4199 I-treatment

The 0 3 4200 4203 O
patient 4 11 4204 4211 O
must 12 16 4212 4216 O
have 17 21 4217 4221 O
an 22 24 4222 4224 O
ECOG 25 29 4225 4229 B-clinical_variable
performance 30 41 4230 4241 I-clinical_variable
status 42 48 4242 4248 I-clinical_variable
of 49 51 4249 4251 O
0 52 53 4252 4253 B-lower_bound
, 53 54 4253 4254 O
1 55 56 4255 4256 B-upper_bound

Total 0 5 4257 4262 B-clinical_variable
bilirubin 6 15 4263 4272 I-clinical_variable
* 15 16 4272 4273 O
≤ 17 18 4274 4275 O
institutional 19 32 4276 4289 O
upper 33 38 4290 4295 O
limit 39 44 4296 4301 O
of 45 47 4302 4304 O
normal 48 54 4305 4311 O
Alkaline 55 63 4312 4320 B-clinical_variable
phosphatase 64 75 4321 4332 I-clinical_variable
≤ 76 77 4333 4334 O
2.5 78 81 4335 4338 B-upper_bound
x 82 83 4339 4340 I-upper_bound
institutional 84 97 4341 4354 I-upper_bound
upper 98 103 4355 4360 I-upper_bound
limit 104 109 4361 4366 I-upper_bound
of 110 112 4367 4369 I-upper_bound
normal 113 119 4370 4376 I-upper_bound
AST(SGOT 120 128 4377 4385 B-clinical_variable
) 128 129 4385 4386 I-clinical_variable
and 130 133 4387 4390 O
ALT(SGPT 134 142 4391 4399 B-clinical_variable
) 142 143 4399 4400 I-clinical_variable
≤ 144 145 4401 4402 O
2.5 146 149 4403 4406 O
x 150 151 4407 4408 O
institutional 152 165 4409 4422 O
upper 166 171 4423 4428 O
limit 172 177 4429 4434 O
of 178 180 4435 4437 O
normal 181 187 4438 4444 O
Creatinine 188 198 4445 4455 B-clinical_variable
Clearance 199 208 4456 4465 I-clinical_variable
≥ 209 210 4466 4467 O
40 211 213 4468 4470 B-lower_bound
ml 214 216 4471 4473 I-lower_bound
/ 216 217 4473 4474 I-lower_bound
min 217 220 4474 4477 I-lower_bound

Women 0 5 4478 4483 B-gender
of 6 8 4484 4486 O
childbearing 9 21 4487 4499 O
potential 22 31 4500 4509 O
must 32 36 4510 4514 O
have 37 41 4515 4519 O
a 42 43 4520 4521 O
urine 44 49 4522 4527 O
pregnancy 50 59 4528 4537 B-pregnancy
test 60 64 4538 4542 O
proven 65 71 4543 4549 O
negative 72 80 4550 4558 O
within 81 87 4559 4565 O
14 88 90 4566 4568 B-upper_bound
days 91 95 4569 4573 I-upper_bound
prior 96 101 4574 4579 I-upper_bound
to 102 104 4580 4582 O
randomization 105 118 4583 4596 O

according 0 9 4597 4606 O
to 10 12 4607 4609 O
WHO 13 16 4610 4613 O
Classification 17 31 4614 4628 O
of 32 34 4629 4631 O
Tumours 35 42 4632 4639 O
( 43 44 4640 4641 O
WHO 44 47 4641 4644 O
Classification 48 62 4645 4659 O
of 63 65 4660 4662 O
Tumours 66 73 4663 4670 O
of 74 76 4671 4673 O
the 77 80 4674 4677 O
Lung 81 85 4678 4682 B-cancer
, 85 86 4682 4683 O
Pleura 87 93 4684 4690 B-cancer
, 93 94 4690 4691 O
Thymus 95 101 4692 4698 B-cancer
and 102 105 4699 4702 O
Heart 106 111 4703 4708 B-cancer
. 111 112 4708 4709 O
WHO 113 116 4710 4713 O
/ 116 117 4713 4714 O
IARC 117 121 4714 4718 O
Classification 122 136 4719 4733 O
of 137 139 4734 4736 O
Tumours 140 147 4737 4744 O
, 147 148 4744 4745 O
4th 149 152 4746 4749 O
Edition 153 160 4750 4757 O
, 160 161 4757 4758 O
Volume 162 168 4759 4765 O
7 169 170 4766 4767 O
) 170 171 4767 4768 O

adequately 0 10 4769 4779 O
treated 11 18 4780 4787 O
non 19 22 4788 4791 B-cancer
- 22 23 4791 4792 I-cancer
melanoma 23 31 4792 4800 I-cancer
skin 32 36 4801 4805 I-cancer
cancer 37 43 4806 4812 I-cancer

curatively 0 10 4813 4823 O
treated 11 18 4824 4831 O
in 19 21 4832 4834 B-cancer
- 21 22 4834 4835 I-cancer
situ 22 26 4835 4839 I-cancer
cancer 27 33 4840 4846 I-cancer

excluding 0 9 4847 4856 O
Gilbert 10 17 4857 4864 B-chronic_disease
's 17 19 4864 4866 I-chronic_disease
syndrome 20 28 4867 4875 I-chronic_disease

known 0 5 4876 4881 O
active 6 12 4882 4888 O
hepatitis 13 22 4889 4898 B-chronic_disease
B 23 24 4899 4900 I-chronic_disease
infection 25 34 4901 4910 I-chronic_disease
( 35 36 4911 4912 O
positive 36 44 4912 4920 O
HBV 45 48 4921 4924 B-chronic_disease
surface 49 56 4925 4932 I-chronic_disease
antigen 57 64 4933 4940 I-chronic_disease
( 65 66 4941 4942 I-chronic_disease
HBsAg 66 71 4942 4947 I-chronic_disease
) 71 72 4947 4948 O
) 72 73 4948 4949 O

known 0 5 4950 4955 O
active 6 12 4956 4962 O
hepatitis 13 22 4963 4972 B-chronic_disease
C 23 24 4973 4974 I-chronic_disease
infection 25 34 4975 4984 I-chronic_disease

known 0 5 4985 4990 O
clinical 6 14 4991 4999 O
diagnosis 15 24 5000 5009 O
of 25 27 5010 5012 O
tuberculosis 28 40 5013 5025 B-chronic_disease

known 0 5 5026 5031 O
human 6 11 5032 5037 B-chronic_disease
immunodeficiency 12 28 5038 5054 I-chronic_disease
virus 29 34 5055 5060 I-chronic_disease
infection 35 44 5061 5070 I-chronic_disease
( 45 46 5071 5072 O
positive 46 54 5072 5080 O
HIV 55 58 5081 5084 B-chronic_disease
antibodies 59 69 5085 5095 O
) 69 70 5095 5096 O

known 0 5 5097 5102 O
pneumonitis 6 17 5103 5114 B-chronic_disease
or 18 20 5115 5117 O
pulmonary 21 30 5118 5127 B-chronic_disease
fibrosis 31 39 5128 5136 I-chronic_disease
with 40 44 5137 5141 O
clinically 45 55 5142 5152 O
significant 56 67 5153 5164 O
impairment 68 78 5165 5175 O
of 79 81 5176 5178 O
pulmonary 82 91 5179 5188 O
function 92 100 5189 5197 O

other 0 5 5198 5203 O
malignancies 6 18 5204 5216 B-cancer
curatively 19 29 5217 5227 O
treated 30 37 5228 5235 O
with 38 42 5236 5240 O
no 43 45 5241 5243 O
evidence 46 54 5244 5252 O
of 55 57 5253 5255 O
disease 58 65 5256 5263 O
for 66 69 5264 5267 O
≥ 70 71 5268 5269 O
5 72 73 5270 5271 B-lower_bound
years 74 79 5272 5277 I-lower_bound
following 80 89 5278 5287 O
the 90 93 5288 5291 O
end 94 97 5292 5295 O
of 98 100 5296 5298 O
treatment 101 110 5299 5308 B-treatment
and 111 114 5309 5312 O
which 115 120 5313 5318 O
, 120 121 5318 5319 O
in 122 124 5320 5322 O
the 125 128 5323 5326 O
opinion 129 136 5327 5334 O
of 137 139 5335 5337 O
the 140 143 5338 5341 O
treating 144 152 5342 5350 O
physician 153 162 5351 5360 O
, 162 163 5360 5361 O
do 164 166 5362 5364 O
not 167 170 5365 5368 O
have 171 175 5369 5373 O
a 176 177 5374 5375 O
substantial 178 189 5376 5387 O
risk 190 194 5388 5392 O
of 195 197 5393 5395 O
recurrence 198 208 5396 5406 O
of 209 211 5407 5409 O
the 212 215 5410 5413 O
prior 216 221 5414 5419 O
malignancy 222 232 5420 5430 B-cancer

potential 0 9 5431 5440 O
must 10 14 5441 5445 O
agree 15 20 5446 5451 B-contraception_consent
to 21 23 5452 5454 I-contraception_consent
use 24 27 5455 5458 I-contraception_consent
adequate 28 36 5459 5467 I-contraception_consent
contraception 37 50 5468 5481 I-contraception_consent

women 0 5 5482 5487 B-gender
of 6 8 5488 5490 O
child 9 14 5491 5496 O
- 14 15 5496 5497 O
bearing 15 22 5497 5504 O

